investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Development of Targeted Therapy for ERK Pathway in Breast Cancer
Chandra Bartholomeusz
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Chandra Bartholomeusz
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Ming Tan
Glucose Metabolism and ErbB2-Mediated Cancer Progression
Breast
Joan Massague
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression
Breast
David C Lyden
Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma
Breast
Zhihong Gong
Aberrant DNA methylation patterns of miRNAs and breast cancer racial disparities
Breast
David E Goldgar
A Comprehensive Approach to Breast Cancer Susceptibility Across the Risk Spectrum
Breast
Bert W O'Malley
Sex Hormone Receptor Components and the Cell Genome
Breast
Ralph Scully
Analysis of BRCA1 Recombination Functions
Breast
Esta Sterneck
Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells
Breast
Mala Pande
Susceptibility Markers for a Breast-Colon Cancer Phenotype
Breast